Abacus Planning Group, Inc. Merck & Co., Inc. Transaction History
Abacus Planning Group, Inc.
- $684 Million
- Q4 2025
A detailed history of Abacus Planning Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 14,117 shares of MRK stock, worth $1.31 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
14,117
Previous 13,255
6.5%
Holding current value
$1.31 Million
Previous $1.11 Million
17.81%
% of portfolio
0.19%
Previous 0.17%
Shares
29 transactions
Others Institutions Holding MRK
# of Institutions
3,968Shares Held
1.9BCall Options Held
29.9MPut Options Held
27.3M-
Vanguard Group Inc Valley Forge, PA254MShares$23.6 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...